The Effectiveness of Calistenic Exercise Training in Adolescents
The Effectiveness of Calistenic Exercise Training in Adolescents Receiving Online Education During COVID-19 Pandemic
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06810
- Baskent University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy adolescent children
Exclusion Criteria:
- Individuals with a disease that could prevent them from doing our exercise training were not included in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: exercise training group
The duration of the study was targeted as 8 weeks.
Our trainings consist of 3 sessions per week, with an average of 45 minutes of calisthenic exercises per session.
Exercises initially started with an average of 30 minutes, 10 repetitions, gradually increased difficulty once every two weeks, time increased to 45 minutes movements were modified for those who were forced to perform the exercise program.
The program was completed with 5 minutes of warm-up and 5 minutes of cooling exercises before exercise training.
All exercises were conducted on a video chat platform supervised by an experienced physiotherapist.
|
these exercises are a kind of exercise for increasing cardiovascular endurance
|
|
No Intervention: control group
no exercise was given
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The levels of physical activity
Time Frame: 8 weeks
|
International physical Activity Survey: The short form, which has improved Turkish validity and reliability, consists of 7 questions.
It provides information about the time spent in severe, moderate walking and sitting activities over the past week.
The total calculated energy is calculated as the met spent per minute.
|
8 weeks
|
|
sleep quality
Time Frame: 8 weeks
|
The Pittsburgh Sleep Quality Index (PSQI) has been used to assess sleep quality.
Applied at start-up and end of 8 weeks.
PSQI allows him to identify disturbances in the last month of his sleep.
It consists of 24 questions in total.
Components are a test that evaluates sleep time, delays in sleep, frequency and severity of sleep-related problems and the impact of poor sleep on the individual's life activity
|
8 weeks
|
|
quality of children's lives
Time Frame: 8 weeks
|
Pediatric Quality of life Questionniare Short Form (PedsQL-SF) has been used to measure the quality of children's lives.
Developed by Varni and his friends in 1999, Memik conducted a study of the validity and reliability of the scale in 2008.
the scale of 23 points is scored in three areas.
On the scale, scores and total points are calculated in the areas of emotional functionality, social functionality and school functionality.
The scale is scored 0,25,50,75,100 points, equal to 4, 3, 2, 1, 0 respectively.
Scale total score, physical health total score is calculated individually and bullet points are collected assessing emotional, social, school functionality, resulting in psychosocial health total score.
The higher the points total, the better the quality of life is concluded
|
8 weeks
|
|
the level of anxiety
Time Frame: 8 weeks
|
The Beck anxiety Scale was used to determine the level of anxiety.
It consists of 21 questions in total.
Each item is rated between 0-3 and 4. All points are collected and the higher the score, the higher the anxiety severity.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- KA20/478
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.